Assessing the repeatability of absolute CMRO 2 , OEF and haemodynamic measurements from calibrated fMRI by Merola, Alberto et al.
Accepted Manuscript
Assessing the repeatability of absolute CMRO2, OEF and haemodynamic
measurements from calibrated fMRI
Alberto Merola, Michael A. Germuska, Kevin Murphy, Richard G. Wise
PII: S1053-8119(18)30108-3
DOI: 10.1016/j.neuroimage.2018.02.020
Reference: YNIMG 14721
To appear in: NeuroImage
Received Date: 24 October 2017
Revised Date: 12 January 2018
Accepted Date: 12 February 2018
Please cite this article as: Merola, A., Germuska, M.A., Murphy, K., Wise, R.G., Assessing the
repeatability of absolute CMRO2, OEF and haemodynamic measurements from calibrated fMRI,
NeuroImage (2018), doi: 10.1016/j.neuroimage.2018.02.020.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 1
Assessing	the	repeatability	of	
absolute	CMRO2,	OEF	and	
haemodynamic	measurements	from	
calibrated	fMRI		
 
Alberto Merola
1,2
, Michael A Germuska
1
, Kevin Murphy
3
 and Richard 
G Wise
1 
 
1- Cardiff University Brain Research Imaging Centre (CUBRIC), School of Psychology, Cardiff 
University, UK 
2- Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, DE 
3- Cardiff University Brain Research Imaging Centre (CUBRIC), School of Physics and 
Astronomy, Cardiff University, UK 
 
 
 
Corresponding author and details:  
 
Professor Richard G. Wise 
Cardiff University Brain Research Imaging Centre 
School of Psychology 
Cardiff University 
Maindy Road 
Cardiff 
CF24 4HQ 
 
Tel: +44 (0)29 2087 0358 (direct) 0365 (reception) 
Fax: +44 (0)29 2087 0339 
Email: wiserg@cardiff.ac.uk 
 	
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 2
Abstract	
As energy metabolism in the brain is largely oxidative, the measurement of cerebral 
metabolic rate of oxygen consumption (CMRO2) is a desirable biomarker for quantifying 
brain activity and tissue viability. Currently, PET techniques based on oxygen isotopes are 
the gold standard for obtaining whole brain CMRO2 maps. Among MRI techniques that have 
been developed as an alternative are dual calibrated fMRI (dcFMRI) methods, which exploit 
simultaneous measurements of BOLD and ASL signals during a hypercapnic-hyperoxic 
experiment to modulate brain blood flow and oxygenation. 
In this study we quantified the repeatability of a dcFMRI approach developed in our lab, 
evaluating its limits and informing its application in studies aimed at characterising the 
metabolic state of human brain tissue over time. Our analysis focussed on the estimates of 
oxygen extraction fraction (OEF), cerebral blood flow (CBF), CBF-related cerebrovascular 
reactivity (CVR) and CMRO2 based on a forward model that describes analytically the 
acquired dual echo GRE signal.  
Indices of within- and between-session repeatability are calculated from two different 
datasets both at a bulk grey matter and at a voxel-wise resolution and finally compared with 
similar indices obtained from previous MRI and PET measurements. Within- and between-
session values of intra-subject coefficient of variation (CVintra) calculated from bulk grey 
matter estimates 6.7±6.6% (mean±std.) and 10.5±9.7% for OEF, 6.9±6% and 5.5±4.7% for 
CBF, 12±9.7% and 12.3±10% for CMRO2. Coefficient of variation (CV) and intraclass 
correlation coefficient (ICC) maps showed the spatial distribution of the repeatability 
metrics, informing on the feasibility limits of the method. 
In conclusion, results show an overall consistency of the estimated physiological parameters 
with literature reports and a satisfactory level of repeatability considering the higher spatial 
sensitivity compared to other MRI methods, with varied performance depending on the 
specific parameter under analysis, on the spatial resolution considered and on the study 
design.     
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Introduction	
Brain activity is reliant on energy release principally through oxidative metabolism. For this 
reason, a number of MRI methods are under development to directly quantify the rate of 
cerebral metabolic oxygen consumption (CMRO2). CMRO2 offers a marker of the 
physiological state of brain tissue (Lin et al., 2010), with potential applications in tumour 
(Brown and Wilson, 2004), stroke (Derdeyn et al., 2002), neurological (Santens et al., 1997) 
and neurodegenerative disorders (Ishii et al., 1996). 
PET imaging based on an oxygen isotope (
15
O) is often still regarded as the gold standard for 
obtaining whole brain CMRO2 maps despite the technical complexity, the risks related to the 
administration of ionising radiation and the implicit limits for longitudinal studies. Recent 
MRI methods for measurement of CMRO2 have been introduced based on exploiting the 
magnetic field differences between the superior sagittal sinus (Jain et al., 2010) or major 
veins (Fan et al., 2012) and the surrounding parenchyma, T2-oxygenation calibration curves 
refined with velocity selective techniques (Bolar and Rosen, 2011; Guo and Wong, 2012) or 
quantifying venous oxygen saturation via the T2 of venous blood (Lu and Ge, 2008; Xu et al., 
2009). While this last approach is limited to bulk level estimates, it is currently found to 
show the highest level of precision and repeatability (Liu et al., 2013). 
Another group of techniques, known as calibrated BOLD methods, aims to estimate CMRO2 
from BOLD and arterial spin labelling (ASL) signals, exploiting respiratory tasks and 
mathematical models describing the complex relationship between oxygen metabolism, 
BOLD signal and cerebral blood flow (CBF) in the brain. Recently, extensions of the original 
approaches of Davis and Hoge (Davis et al., 1998; Hoge et al., 1999) have been developed 
allowing the use of both hypercapnia and hyperoxia induced CBF and BOLD signal changes 
within the same experiment, to estimate cerebral venous deoxyhaemoglobin concentration 
and thus oxygen extraction fraction (OEF) and absolute CMRO2 (Bulte et al., 2012; Gauthier 
and Hoge, 2012; Wise et al., 2013), an approach also known as quantitative O2 imaging 
(QUO2) or dual calibrated fMRI (dcFMRI).  
Eliminating the use of PET ionising agents in mapping CMRO2 is desirable, although one of 
the factors that currently limit the application of dcFMRI methods in clinical research studies 
is the lack of characterisation of their variability and repeatability. In fact, to our knowledge 
only a single study based on a dcFMRI technique (Lajoie et al., 2016) has been recently 
presented reporting repeatability measurements. This involved a cohort of eight healthy 
subjects undergoing two separate dcFMRI scan sessions (within 24 hours) and the data were 
analysed with a QUO2 estimation approach (Gauthier and Hoge, 2012), supplying estimates 
of whole brain grey matter and regional repeatability.  
Our study also focuses on characterising the repeatability of the dcFMRI technique, 
although considering estimates obtained from dcFMRI experiments with a novel estimate 
approach based on a forward model recently developed in our lab (Germuska et al., 2016). 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 4
This model allows us to describe analytically the contributions of BOLD signal, ASL signal and 
of the measured end-tidal partial pressures of CO2 and O2 to the measured dual echo GRE 
signal in a dcFMRI acquisition, at a voxel-wise level of resolution (see Appendix for more 
details). We are therefore able to present quantitative maps of four main physiological 
parameters involved in brain metabolism across grey matter: OEF, CBF, CO2-induced 
perfusion cerebrovascular reactivity (CVR) and CMRO2.  
Our aim is to evaluate the reliability of the estimates and to collect reference data to 
evaluate the limits and the viability of the estimation framework for adoption in future 
studies aimed at characterising the metabolic state of human brain tissue. Compared to the 
work of Lajoie and colleagues (Lajoie et al., 2016), a more extended cohort of subjects and 
set of measurements are considered for this study. Indices quantifying within-session 
repeatability of the estimates are presented, based on measurements from a test-retest 
experiment on ten healthy volunteers in the resting state. A second group of indices 
quantifying between-session repeatability of the results is also presented, based on a 
previously published study on sixteen healthy volunteers exploiting the same dcFMRI 
analysis framework but a crossover design with repeated measurements (Merola et al., 
2017). We quantify repeatability both at a whole grey matter level and at a voxel-wise level, 
supplying a good level of spatial detail for such measurements.  
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Materials	and	methods	
Participants and experimental design 
Exclusion criteria were introduced with special attention to possible difficulties in complying 
with respiratory tasks (asthma, smoking, cold/flu, etc.) and known cardio/cerebrovascular 
disease. Volunteers’ tolerance of hypercapnic periods and prolonged breathing through a 
facial mask was tested with a benching session held in the days before the scanning session. 
The study was approved by the local ethics committee and written informed consent was 
obtained from each participant.   
For within-session assessments ten healthy volunteers (4 females, age = 27.4±10) were 
recruited. Each participant was scanned at rest (eyes open) in a single scan session (see 
Figure 1, top). A dual calibrated fMRI scan (dcFMRI scan, 18 min) was performed and then 
repeated after about 10 minutes. During each of the dcFMRI scans an 18 min respiratory 
task was delivered, with interleaved levels of hypercapnia, hyperoxia and medical air being 
delivered to the subjects. We will refer to this as the within-session repeatability dataset.  
For between-session assessments a second set of measurements is included from a 
previously presented dcFMRI study on the acute effects of caffeine for which sixteen 
healthy participants (8 females, age = 24.7±5.1) were recruited (Merola et al., 2017). The 
results from one subject were excluded, due to the degraded nature of the data (please 
refer to the original paper (Merola et al., 2017)). In this case each participant was scanned 
on two different days (30.1±18.8 days apart, same time of the day), each day including the 
same protocol with a first scan session followed by the delivery of a capsule of drug or 
placebo outside the scanner and then a second scan session 45 minutes later (see schematic 
in Figure 1). Crucially in each day the dcFMRI acquisitions were run in two separate scanning 
sessions, with the participant spending time outside the MR suite in between them. For the 
purpose of this study only the pre-dose and placebo sessions were considered (see 
schematic in Figure 1) to avoid the caffeine effect. Each session included a dcFMRI 
acquisition with specifications and respiratory tasks identical to the ones used for the 
within-session repeatability dataset. We will refer to this as the between-session 
repeatability dataset.  
Gas delivery, breathing circuit and respiratory task 
The respiratory task design we adopt is similar to interleaved paradigms previously 
presented in literature (Bulte et al., 2012; Wise et al., 2013) and was optimized using noise 
modelling as previously described (Germuska et al., 2016). The design includes three periods 
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of hypercapnia interleaved with two periods of hyperoxia, for a total duration of 18 minutes 
(see Figure 2, A). In order to achieve hypercapnia, fixed values of 5% CO2 (balance air) were 
administered. Inspired fractions of 50% O2 (balance air) were delivered to achieve 
hyperoxia. Although in this last case, the levels of administered gas were modified with 
positive and negative emphasis; short periods of respectively 100% O2 (14s) and 10% O2 
(40s) were delivered in order to accelerate the process of reaching the hyperoxic state and 
the return to normoxia (see Figure 2). Although hypoxic mixtures were administered, their 
short duration did not induce arterial hypoxia, as monitored by a pulse oximeter attached to 
the volunteers’ finger. Mixtures of 5% CO2 (balance air), 10% O2 (balance N2), 100% O2 and 
medical air were delivered at a total flow rate of 25 l/min to the gas mixing chamber which 
was placed in the MR control room. The mixing chamber was then connected to the 
breathing circuit through a humidifier. An independent O2 backup cylinder was also 
connected directly to the breathing circuit. The gas delivery system consisted of a laptop 
personal computer using in-house Matlab software (Mathworks, Natick, MA, USA) to control 
the voltage output from a NI-DAQ AD converter (National Instruments, Austin, TX). The 
output voltages were then fed into four mass flow controllers (MKS Instruments, 
Wilmington, MA, USA) that allowed us to administer the desired gas mixture. The 
respiratory circuit adopted was similar to the one proposed by Tancredi and colleagues 
(Tancredi et al., 2014). This circuit includes a system of one-way valves that minimizes re-
breathing and an open reservoir that allows the subject to breathe room air when flow 
ceases to the circuit. Air was sampled from the volunteers’ tight-fitting facemask and tidal 
partial pressures of O2 and CO2 were measured and recorded using rapidly responding gas 
analysers (AEI Technologies, Pittsburgh, PA, USA).  
 
Data acquisition 
For both datasets presented, scanning was performed on a 3T GE HDx MRI system (GE 
Healthcare, Milwaukee WI) with a body transmit coil and 8-channel head receive coil. All 
participants underwent (or had available) whole brain T1-weighted structural scans (3D 
FSPGR, 1x1x1 mm voxels, TI/TR/TE = 450/7.8/3 ms).  
dcFMRI acquisitions were acquired for both within- and between-session repeatability 
datasets collecting simultaneous perfusion and BOLD imaging data with a PASL PICORE, 
QUIPSS II imaging sequence with a dual-gradient echo (GRE) readout and spiral k-space 
acquisition with the following parameters: TE1 = 2.7 ms, TE2 = 29 ms, TR = 2.2 s, Flip Angle = 
90°, FOV = 22 cm, Matrix = 64 x 64, 12 slices of 7 mm thickness with an inter-slice gap of 1 
mm acquired in ascending order, TI1 = 700 ms, TI2 = 1500 ms for the most proximal slice and 
was incremented for the subsequent slices, tag thickness = 20 cm, 10 mm gap between 
labelling slab and bottom slice, 10 cm QUIPSS II saturation band thickness. This resulted in a 
490-volume acquisition (245 tag-control pairs) for each of the dcFMRI acquisitions.  
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All dcFMRI scans were preceded by two calibration scans. The first consisted of a single shot 
scan to estimate the equilibrium magnetization of brain tissue (M0), used for perfusion 
quantification (Çavuşoǧlu et al., 2009), with the same acquisition parameters as for the 
perfusion-weighted scans, except for being acquired with fully relaxed magnetization and no 
labelling. The second was a low resolution, minimal contrast image used for coil sensitivity 
correction (Wu et al., 2011), with the same acquisition parameters as for the equilibrium 
magnetization scan, except for TE = 11 ms and TR = 2 s. 
Data analysis 
dcFMRI	data	and	end-tidal	traces	
dcFMRI data were pre-processed with motion correction (MCFLIRT, (Jenkinson et al., 2002)) 
and brain extraction (BET, (Smith, 2002)) and spatially smoothed with a Gaussian kernel of 6 
mm with SUSAN (Smith and Brady, 1997), separately for echo 1 and echo 2. Estimation of 
physiological parameters of interest was performed with the forward model previously 
developed in our lab (Germuska et al., 2016) adapted for a Bayesian approach. This model - 
described in the Appendix section - was adopted because it allows us to take into account 
different aspects of physiology contributing to the measured BOLD and ASL signals in a 
simultaneous optimization and also because it is less prone to estimation failure compared 
to previous calibrated fMRI methods (Germuska et al., 2016). The priors on estimates were 
defined specifying means and standard deviations (mean, std.) as OEF = (0.35, 0.1), CBF = 
(60, Inf) ml/100g/min, CVR = (3, 0.774) %mmHg, where by “Inf” we mean a non-informative 
prior. These values were fixed in agreement with reported physiological ranges and 
consistently with those used in the original study on the Bayesian framework for the 
forward model (Germuska et al., 2016). A prior was also defined on the estimated 
parameter K = (0.07,0.087), as for a recent study from our centre (Merola et al., 2017). Non-
informative priors are used to initialize the estimate without carrying information, therefore 
they can be thought of as uniform distributions of probability. No prior is defined on the 
estimates of CMRO2 as this is calculated as CMRO2 = CBF·OEF·CaO2 (see Eq. A-11 in 
Appendix), where CaO2 is the arterial content of oxygen. With regards to the remaining 
parameters, they were kept the same as those adopted in the original work (Germuska et 
al., 2016) as also reported in Table 2 in the Appendix.  
The inputs to the framework are dual echo GRE images and, PetO2 and PetCO2 traces. 
Analytic models (see Equations 1-8 in (Germuska et al., 2016) and the Appendix section) 
describing the magnetization decay occurring at the first and second TE were used to 
estimate grey matter maps of OEF, CBF, CVR and CMRO2. As for the parameters α and β 
used in Eq.5 of (Germuska et al., 2016), they were fixed to 0.06 and 1 respectively, following 
the results of our previous optimisation study (Merola et al., 2016). Prior to analysis, the 
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end-tidal responses were visually aligned with the MR data to remove the influence of any 
bulk delay between the recorded end-tidal traces and the fMRI data. Possible alignment 
errors amount to fractions of TR and likely have a negligible effect on the final estimation. 
Low-resolution functional images (mean TE1 across time) were co-registered to the high-
resolution T1 weighted anatomical space using FSL FLIRT (Jenkinson et al., 2002) with 6 DOF 
for each subject. Registrations from the individual anatomical space to the MNI space were 
calculated with FNIRT (Andersson et al., 2007) for second level analysis. The parametric 
maps obtained from the analysis pipeline in the low-resolution functional space, were finally 
expressed into the MNI space using the calculated spatial transformations. 
Mean grey matter values of each estimated parameter were calculated for the scans from 
an inclusive joint mask defined by I) partial volume grey matter values (based on the 
individual FSL FAST segmented high resolution anatomical maps) greater than 50%, II) 
estimated values of CBF within the range [0 200] ml/100g/min. The first criterion was 
imposed as an empirical threshold to avoid values affected by poor SNR of the signal in 
white matter, while the second was used to exclude non-physiological values, likely 
associated with high noise in some areas of the ASL images. A small proportion of voxels for 
which the estimation algorithm did not converge were also excluded from the analysis.  
Within-session	repeatability	analysis	
Indices quantifying the repeatability of the estimates were calculated for each physiological 
parameter both at a bulk grey matter and the voxel-wise level and are summarised in the 
table of Figure 1.  
Firstly indices were calculated at a bulk grey matter level with a correlation analysis 
between the estimates at the two time points: coefficient of determination (R
2
) and 
statistical significance (p).  
Then the intraclass correlation coefficient, or ICC (McGraw and Wong, 1996; Shrout and 
Fleiss, 1979), was used as a measure of absolute agreement between the bulk estimates. 
The ICC has previously been applied to fMRI data to quantify the ratio between the data 
variance of interest and the total data variance (Bright and Murphy, 2013; Lipp et al., 2015). 
In particular, it can be applied in a voxel-wise fashion in order to obtain estimates of spatial 
repeatability of the signal (Lipp et al., 2014). Two different ICC indices were therefore 
considered: one calculated on whole grey matter values of the parameters across subjects 
(corresponding to ICC(A,k) in (McGraw and Wong, 1996)) and another considering voxel-
wise comparisons between the two scans for each participant separately (corresponding to 
ICC(A,1) in (McGraw and Wong, 1996)). These are hence referred to as “global ICC” (ICCglobal) 
and “spatial ICC” (ICCspatial) respectively (see table in Figure 1). Both are interpreted 
according to commonly used guidelines that classify values of ICC below 0.4 as “poor”, 
values between 0.41 and 0.59 as “fair”, values between 0.60–0.74 as “good” and values > 
0.74 as “excellent” (Cicchetti, 2001). 
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In order to evaluate the spread of the bulk estimates around their mean values, coefficients 
of variation (CV) of the estimates were also calculated. Two CV indices were considered: one 
taking account of the differences between the subjects of the cohort (i.e. inter-subjects, 
CVinter) and the other considering the variability occurring in each subject separately (ie 
intra-subject, CVintra, see table in Figure 1). CVinter was calculated as the mean of the CV 
values calculated for the two sessions, each of which was obtained as the ratio between the 
standard deviation and mean. CVintra was calculated for each person by dividing the standard 
deviation of the estimates from two sessions by their mean. These CV indices were also 
visually represented in Bland-Altman plots, scatterplots in which the differences between 
two set of measurements are plotted against their means. Calculating the mean (m) and 
standard deviation (std) across the differences, it is then possible to characterise as outliers 
the values lying beyond the interval of m ± 1.96*std. 
The relationship between the similarity of the respiratory traces in the two acquisitions, 
expressed as a correlation, and the estimated indices of CVintra was investigated, looking for 
possible sources of nuisance influencing intra-session variability. 
Indices were also calculated at a voxel-wise level. Maps of the ICC index for each estimated 
parameter were calculated measuring the absolute agreement between each voxel across 
subjects (corresponding to ICC(A,1) in (McGraw and Wong, 1996)). As for the bulk case, two 
indices were considered for CV: CVinter was calculated as the mean between the CV (=std/m) 
values calculated for each of the two sessions. CVintra maps were also calculated for each 
subject as the ratio between the standard deviation and the mean of the two 
measurements. Differently from the bulk estimates, a single map denoted <CVintra> was then 
calculated as the mean of each subject’s CVintra map, for an easier comparison with the 
CVinter map (see table in Figure 1). 
 
Between-session	repeatability	analysis	
Between-sessions repeatability was assessed similarly to the within sessions analysis but 
considering the dataset from our previous study on caffeine effects (see schematic in Figure 
1).  
In order to avoid the effects of caffeine, only the three acquisitions without caffeine 
administration were considered in this case (i.e. both acquisitions in day 1 and the first in 
day 2, see Figure 1). Therefore in this instance two different sets of measurements were 
calculated: the first comparing data acquired in different sessions but on the same day, 
which we shall refer to as “same day, between sessions repeatability” (or “between, same 
day”), while the second comparing different sessions and different days, which we shall 
refer to as “different day, between sessions repeatability” (or “between, different day”, see 
Figure 1).  
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At a bulk level, measurements of between-session correlation were calculated: CV (CVintra 
and CVinter) and ICC (ICCglobal and ICCspatial). Then maps of the CV (<CVintra> and CVinter) and ICC 
indices were also calculated. All measurements are defined as for the within session case 
and are given for both same day- and different day-, between sessions repeatability. 
The code used in this manuscript for data analysis is openly available from the Cardiff 
University data archive http://doi.org/10.17035/d.2017.0041693648. However, due to 
ethical considerations open access cannot be given to the in vivo subject data or data 
derived from this. 
 
 	
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 11 
Results	
Within-session dataset 
Respiratory	traces	and	bulk	results	
The mean baseline PetO2 value was 113 mmHg, while it was 42 mmHg for PetCO2. Plateau 
levels of hyperoxia caused a mean increase of approximately 230 mmHg in PetO2 and the 
mean increase in PetCO2 from baseline with hypercapnia was 11.5 mmHg. Moreover, 
periods of hyperoxia appear to produce a reduction in PetCO2 of about 2 mmHg, while 
periods of hypercapnia showed an increase in PetO2 of approximately 10 mmHg, 
consistently with literature findings (Floyd et al., 2003; Tancredi et al., 2014). The averaged 
end-tidal traces for this dataset and an example of tidal measurements from a single subject 
are reported in Figure 2 B,C. 
With regards to grey matter values of the four estimated physiological parameters, means 
calculated across subjects show only slight and not significant differences between the two 
time points, with pooled mean values of 0.38 (SEM ±0.024) for OEF, 56 (SEM ±3.8) 
[ml/100mg/min] for CBF, 2.6 (SEM ±0.15) [%/mmHg] for CVR and 183 (SEM ±16) 
[μmol/100mg/min] for CMRO2. 
Results of the correlation analysis are reported for all parameters in Figure 3. In this case the 
goodness of fit is mixed: while OEF and CBF show relatively high values of the coefficient of 
determination (R
2
>0.7), CVR and CMRO2 only show moderate agreement between the two 
measurements (R
2
>0.5).    
With regards to the ICC indices, ICCglobal is found to be “excellent” for all four parameters, 
with particularly high performances for OEF and CBF (>0.9, Figure 4,A). Results are more 
varied for the voxel-wise analysis, with values of ICCspatial remarkably high for CBF, mostly 
“excellent” for CVR and CMRO2, while mostly “good” for OEF.   
Figure 4,B also shows CV indices. Values of CVinter are generally high, ranging between 17.5% 
for CVR to 26.9% for CMRO2. CVintra indices have similar distributions across parameters, 
with a value (mean±std.) of 6.7±6.6% for OEF, 6.9±6% for CBF, 9.5±8.8% for CVR and 
12±9.7% for CMRO2. In only three cases (not corresponding to the same subject) CVintra is 
higher than CVinter.  
Figure S1 in the Supplementary Material reports the linear relationship between the 
similarity of the respiratory traces in the two sessions - calculated as correlation - and the 
estimated indices of CVintra for OEF. Results show a significant negative association among 
the two, although this effect is not found for the remaining physiological parameters 
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estimated. Notably the two subjects with highest CVintra also show the lowest values of 
correlation for CO2 and O2 traces between runs.  
Bulk results visualised with Bland-Altman plots (reported in the Supplementary Material 
section, Figure S2) show most of the values clustering around the pool means for OEF and 
CVR, with bias in the differences of 4.9% and -6.5% respectively compared to the relative 
mean. For these parameters it is also possible to find an outlier (not always corresponding 
to the same subject). Distributions for CBF and CMRO2 are instead broader, with bias in the 
differences of just -0.4% and 4.6% respectively and no apparent outliers. 
Voxel-wise	results	
Maps of the CV indices at a voxel-wise level and their normalised histograms are reported in 
Figure 5. As for the bulk estimates, values of the mean of the intra-subject CV are generally 
lower than values of inter-subjects CV. Notably, for all physiological parameters areas of 
interface between grey matter and different structures (white matter, ventricles and skull) 
present higher CV values. For both <CVintra> and CVinter, CBF shows the lowest variability, 
with values mostly homogeneous across parameters apart from few focal areas. A similar 
situation is shown by OEF and CVR, but with higher estimates. CMRO2 shows instead high 
<CVintra> and CVinter indices with irregular distributions in space. The histograms support such 
evidence, with positively skewed distributions and median values lying around 25% for 
<CVintra> while above 50% for CVinter.  
Finally, Figure S3 in the Supplementary Material section shows maps of the ICC index for 
each parameter and normalised histograms. The spatial distribution of the ICC is similar to 
that of the CV indices, with lower values associated with areas of interface between grey 
matter and different structures and CBF results showing the higher degree of uniformity. 
This is supported by the distributions, which all present negative skewness and with the best 
performance associated with the estimates of CBF reporting a median of 0.76 (classifiable as 
“excellent”), while for the remaining parameters the median lies between 0.55 for CVR and 
0.60 for CMRO2.  
 
Between-sessions dataset 
Bulk	results	
The effects elicited by the respiratory task are consistent with those found for the within-
session repeatability dataset, with mean baseline values were 113 mmHg for PetO2 and 39 
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mmHg for PetCO2, with mean changes from baseline due to hypercapnia and hyperoxia of 
12 mmHg and 211 mmHg respectively. 
Results of the correlation analysis for the between sessions datasets are reported in Figure 6 
and Figure 7 for same and different days respectively. Values of correlation are overall lower 
than for the within-session dataset, with results from the same day found to be higher than 
those from different days.  In both these last two cases, the correlation is particularly good 
for CBF with high values of the coefficient of determination (R
2
>0.7). Satisfactory levels of 
agreement are also reported for CVR in the case of between, same-day, while for the other 
estimated parameters the agreement is poorer.  
CV indices reported in Figure 4 D,F appear similar among the two instances of the between-
sessions repeatability. Values of CVinter are generally higher, ranging between about 25% for 
CVR to about 15% for OEF. CVintra shows values (mean±std.) of 10.8±10% for OEF, 4.4±2.7% 
for CBF, 12.5±9.1% for CVR and 11.2±9.7% for CMRO2 in the between sessions - same day, 
while of 10.5±9.7% for OEF, 5.5±4.7% for CBF, 17.5±17.9% for CVR and 12.3±10% for 
CMRO2 in the between sessions - different day. The distribution of CVintra indices generally 
shows lower performances and outliers up to about 55% in the case of different days.  
ICCspatial indices are found to be overall consistent among same day and different day 
acquisitions for all four parameters, with mean values typically above 0.65 and a few 
outlying low values for the latter case (Figure 4 C,E). Results are more varied for the bulk 
analysis, with values of ICCglobal remarkably high for CBF in both cases, mostly “good” for CVR 
for the same day case, while “poor” for the rest, with the different day instance reporting 
the worse performances. In general, the performances reported are lower than for the 
within-session analysis.  
The correlation analysis between the similarity of the respiratory traces in the two sessions 
and the estimated indices of CVintra for the different physiological parameters did not show 
any significant results for the between sessions datasets (results not shown).  
Voxel-wise	results	
Maps of the CV indices and normalised histograms for both same day- and different day-, 
between sessions repeatability are reported for each parameter in Figure 8. Notably, for all 
physiological parameters areas of interface between grey matter and different structures 
and areas of the occipital lobe present higher CV values. As for the within session case, CBF 
shows the lowest variability, with values mostly homogeneous across parameters apart 
from a few areas, while CVR shows high <CVintra> and CVinter indices with less regular 
distributions in space. Histograms show that for all parameters distributions of <CVintra> 
(Figure 8 A,C) are shifted towards lower values compared to CVinter (Figure 8 B,D). The 
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distributions are instead very similar when comparing indices obtained in acquisitions from 
the same day (Figure 8 A,B) against acquisitions in different days (Figure 8 C,D), with only a 
slight increase in the latter case.  
Finally Figure S4 in the Supplementary Material section shows maps of the ICC index for 
each parameter and normalised histograms. In both cases the spatial distribution of the ICC 
results is in agreement that found for CV indices, with maps from the same day (Figure S4, 
A) very similar to maps from different days (Figure S4, B) and CBF results showing the higher 
performance in general. This is supported by the relative histograms, with only CVR values 
resulting appreciably higher for same-day acquisitions, while in contrast CBF values being 
even higher for different-day acquisitions. In general ICC values appear lower than the 
within-session case, with most distributions having median values below 0.5 and small but 
non-negligible proportion of negative values.  
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Discussion	
The present study aims to quantify the repeatability of a novel estimation approach based 
on a dcFMRI experiment, providing reference data characterising variability of CBF, CVR, 
OEF and CMRO2 estimates and thus informing the design of future dcFMRI studies. An 
analogous study recently evaluated the bulk and regional reproducibility of physiological 
parameters including OEF and CMRO2 estimates obtained with a similar dcFMRI calibration 
approach (Lajoie et al., 2016). In the present study we provide additional assessments of 
repeatability by comparing within and between (same- and different- day) session variability 
using two groups of subjects. Moreover, maps of the spatial distribution of the variability 
were obtained from a voxel-wise analysis.  
With regards to the within-session dataset, grey matter values estimated with our forward 
model show an overall consistency of the results between the sets of measurements taken 
at two time points. Measured global grey matter values of 0.38±0.08 (mean±std) for OEF are 
in agreement with our previous reports (0.42±0.12, (Wise et al., 2013)) or from other 
centres, with typical values for other MR methods ranging between 0.26 (Bolar and Rosen, 
2011) and 0.435 (Fan et al., 2016). Notably, the variability of the reported whole brain 
estimates of OEF performs well compared to results from recent similar studies with dual 
calibrated fMRI approaches. Values of 0.43±0.08 and 0.39±0.06 in young (N=28) and older 
(N=45) subjects were found by De Vis et al. (De Vis et al., 2015), values of 0.435±0.14 and  
0.423±0.17 were reported by Fan and colleagues for different application of the QUO2 
method (N=11, (Fan et al., 2016)) and finally values of 0.37±0.06 were shown by Lajoie and 
colleagues (N=8, (Lajoie et al., 2016)) again with QUO2. 
Global grey matter measures of CBF (56 ml/100mg/min) tend to be higher than what 
typically reported for MRI and PET studies (41 ml/100mg/min (Bulte et al., 2012), 42 
ml/100g/min (Ibaraki et al., 2010)), but they are consistent with those from our previous 
study and similar ones, especially when considering young cohorts (56 ml/100mg/min (Wise 
et al., 2013), 52 ml/100mg/min (Gauthier and Hoge, 2012) and 63 ml/100g/min (Ances et 
al., 2009)). Estimates of 2.6±0.47 %/mmHg for CVR lie on the lower side of the typical range 
of values obtained for comparable CO2 challenges in most of the MRI literature (between 
5.15±1.1 %/mmHg (Bulte et al., 2012) and 2.82±1.21 %/mmHg (Heijtel et al., 2014)).  
Finally mean CMRO2 values of 183±49 μmol/100g/min are comparable to reported values 
obtained with the dual calibrated fMRI method previously presented by our lab (184±45 
μmol/100g/min (Wise et al., 2013)), other calibrated fMRI methods (145±30 μmol/100g/min 
(Gauthier and Hoge, 2012) and 155±39 μmol/100g/min (Bulte et al., 2012)) and values of 
182±12 μmol/100g/min (Liu et al., 2013), 158±18 μmol/100g/min (Fan et al., 2012) and 
157.4±19.7 μmol/100g/min (Roland et al., 1987) obtained with different MR methods and 
PET. In terms of variability around the mean value, our results are comparable with 
estimates of 181±60 and 133±43 μmol/100g/min in young (N=28) and older (N=45) subjects 
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respectively recently reported by De Vis and colleagues (De Vis et al., 2015) and with the 
values of 143±34 shown by Lajoie and colleagues (Lajoie et al., 2016). Nevertheless in our 
study a few subjects show substantial changes between the two time points or outlying 
values, highlighting a degree of noise in the estimates, especially with regards to CVR and 
CMRO2.  
The correlation analysis for the within session dataset shows a generally good level of 
correlation between the estimates, although highlights less than optimal performances in 
the cases of CVR and CMRO2. In particular, in Figure 3-C,D few subjects appear as outliers. 
The main cause can be found considering the nature of the measurements, as both are 
derived from other estimates: CVR as the ratio between percent change in CBF and absolute 
changes in PetCO2 while CMRO2 as the product of OEF and CBF. This means that they are 
particularly sensitive to cumulative effects of noise in the original measurements.  
ICC indices provide further quantification of the absolute agreement between the 
estimates: high values for the ICCglobal index support the good performance found in the 
correlation analysis, while calculated ICCspatial indices inform about consistency at a voxel-
wise level. As expected, ICCspatial is generally lower than ICCglobal because averaging the 
estimate across grey matter allows some of the noise contributions to be reduced. In fact it 
might be argued that the good agreement of the estimates at a grey matter level is simply 
due to the averaging operated on a possibly wide range of noisy and non-informative 
estimates. Our analysis gives evidence that this is not the case: in fact ICCspatial indices and 
the maps of ICC show that estimates are generally spatially consistent also at a voxel-wise 
level. 
A further understanding of the variability in the within session data is given by the 
calculated coefficients of variance. CVinter and CVintra indices measure the proportion of the 
variability in the estimates originating from inter-subjects differences (such as normal 
distribution of physiological parameters in the cohort) and intra-subject differences (more 
related to measurement error, on the assumption of stable physiology). As values of CVintra 
are found to be generally lower than CVinter, this means that the method applied is accurate 
enough to capture the single subject’s physiology. Moreover, grey matter CVintra values of 
6.7±6.6% (mean±std.) for OEF, 6.9±5.9% for CBF and 12±9.6% for CMRO2 are comparable 
with those reported in PET literature for other methods aiming at estimating brain 
metabolism and haemodynamics across brain (5.7±4.4%, 8.4±7.6% and 5.3±3.9% 
respectively for (Coles et al., 2006) and 9.3%, 8.8% and 5.3% respectively for (Bremmer et 
al., 2011). With regards to MRI, results are higher than those reported for bulk estimates 
coupling TRUST measurements and phase contrast imaging for CBF (3.2±1.2%, 2.8±0.8% and 
3.8±1.4% respectively (Liu et al., 2013)) but comparable with the values reported  for the 
only fMRI calibrated study that addressed the issue of repeatability so far (about 4%, 13.5% 
and 15% respectively with QUO2 (Lajoie et al., 2016)). It is worth noting that in both this last 
example and our study, bulk grey matter results are obtained excluding voxels in which the 
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estimation algorithm fails to converge to a solution or presents invalid estimates. The 
proportion of included voxels of the total considered is 88.5±6% (m±std) for that study (see 
Table 3 in (Lajoie et al., 2016)) and it is 96±2% for our study.  This is consistent with our 
previous report showing lower proportions of valid estimates obtained with the QUO2 
analysis method compared to our forward modelling approach (Germuska et al., 2016). By 
neutralising the variability contribution from these problematic voxels, the repeatability 
estimates from Lajoie et al., (2016) may show higher performance but would have a 
decreased spatial coverage compared to those reported in our study.  
A significant source of nuisance for the within-session repeatability appears to be related to 
the variations in the end tidal responses to the respiratory task between different 
acquisitions, at least for estimates of OEF. In fact the negative correlation found in Figure S1 
in the Supplementary material indicates that changes in such response are correlated to 
higher CVintra indices. Although, it is not possible to infer whether this is a causal relationship 
or such correlation is determined, for example, by a third underlying physiological variable.    
The Bland-Altman plots (Supplementary material, Figure S2) visualize the relationship 
between the inter-subject and intra-subject variability, or measurement precision. Results 
confirm what was seen for the ICC and CV indices, that is a generally good agreement of the 
estimates in the two time points with a few outliers lowering the performance. It is also 
highlighted how values of OEF are mostly clustered around a physiological “average” value, 
whereas more varied values are found for CBF and CMRO2. 
Voxel-wise CV indices are higher than those reported for bulk estimates, typically by a factor 
of 2 and 3 for the intra- and inter-subjects case respectively. Similarly, voxel-wise ICC indices 
show lower performance. This is expected due to the higher spatial resolution but it tells us 
about the spatial distribution of the variability in the estimates. In particular they show that 
the low CV indices calculated at a bulk level for OEF and CBF are representative of the voxel-
wise distribution of these indices. Maps of CMRO2 further support the notion that the 
precision of the estimates is degraded by the combination of both OEF and CBF variability.      
Results from the between-sessions analysis give us a further insight into the repeatability of 
the measurements obtained with our method for applications with acquisitions obtained 
during the same day but in different scanning sessions or in two different days. Compared to 
the within-session case, levels of repeatability are expected to decrease due to increasing 
levels of experimental variability, related to running two different sessions in the MRI 
scanner, and enhanced intra-subjects physiological variability (in the between, different day 
case), with possible variations in the participants’ haemodynamic and metabolic state across 
time. In fact performance does decrease somewhat, with the lowest repeatability being 
between day for CMRO2, whose estimates subject to the cumulative effects of errors in CBF 
and OEF measurements. Notably, the correlation of OEF estimates shown in Figure 6 and 
Figure 7 appears to be particularly poor. This could be driven by the relatively low 
physiological variance in true values of OEF rather than by the accuracy of our methods. In 
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fact while values of CBF are found to vary considerably in the healthy brain depending of 
multiple factors such as age and gender, OEF typically varies within a narrower range of 
values, with an average of about 0.4 (in the healthy brain (Buxton, 2009), this being also 
observed for the within-session dataset and visible in Figure S2,A). This would manifest as 
scatterplots with isotropic distributions (rather than aligned along the unitary line) despite 
relatively low levels of CV indices, as reported by our analysis. 
A first caveat in the present study relates to the application of our method under the 
assumption of isometabolism during hypercapnia and hyperoxia when performing 
respiratory tasks. Studies on the dependence of CMRO2 on altered arterial CO2 and O2 levels 
have found variable results, with some of the more relevant ones pointing at a decrease in 
metabolism with both hyperoxia and hypercapnia (Xu et al., 2012, 2011). An eventual 
deviation from isometabolism during these conditions would translate into bias on the 
estimates from calibrated fMRI models, as reported by studies from our and other groups 
(Merola et al., 2016, Blockley et al., 2015). In particular, we would expect values of OEF to 
be overestimated if CO2 lowered O2 metabolism, while values of OEF would be 
underestimated if O2 lowered O2 metabolism (Merola et al., 2016). Due to the form of the 
forward model, estimates of CBF are not expected to be affected by the violation of 
isometabolic conditions. Although still the subject of discussion in the field, this is a 
commonly adopted assumption for calibrated fMRI methods. 
Another limitation arises from the precision of the estimates obtained with the forward 
model. As previously discussed, grey matter values reported are generally consistent with 
those found in literature. Repeatability of the measurement, quantified with correlation 
analysis and ICC calculations, has been shown to be overall satisfactory for the within-
session repeatability, both at a bulk and voxel-wise level, the worst performances being 
related to the inherently noisiest derived parameters, i.e. CVR and CMRO2. CV indices are 
instead higher than those reported in literature for alternative MRI bulk measurements, as 
previously discussed. Although this does not represent a major limitation as in most cases 
values of CVintra are lower than CVinter, indicating that the estimation precision of a subject’s 
parameters is still good enough not to be confounded by the cohort’s variability. In fact we 
should note that the estimates of four physiological parameters presented here have a 
voxel-wise resolution. Therefore, a trade-off between repeatability and spatial resolution 
has to be considered when comparing them to other methods only allowing bulk estimates 
of fewer parameters such as TRUST (Lu and Ge, 2008) or susceptibility methods applied to 
major veins (Fan et al., 2012; Jain et al., 2010). In our approach while the reproducibility is 
dependent on many factors, it is heavily conditioned by the ASL signal, which shows the 
lower SNR compared to the BOLD-weighted measurements. Therefore possible strategies to 
improve reproducibility would be preferentially focused on enhancing the quality of the ASL 
signal, for example adopting a pCASL tagging scheme or background suppression.  
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The final issue originates from the Bayesian approach adopted for the estimates. In fact the 
use of priors could potentially bias the estimates towards pre-determined values (the priors 
themselves) rather than the real ones. This would translate into good repeatability and 
decreased variability in the data, but ultimately resulting in a loss in sensitivity to differences 
in individual physiology. This argument, however, seems to be contradicted by the evidence 
of physiologically meaningful variation of estimates across grey matter and the presence of 
outlying values. Furthermore, also findings from previous studies in our centre point against 
this possibility. In fact, increased sensitivity to physiological changes was shown for the 
forward model used compared to other approaches (Germuska et al., 2016) and significant 
changes in physiology were found after caffeine consumption despite fixed priors (Merola et 
al., 2017). 
Finally, this work helps us to design future studies based on the same estimation 
framework. By way of example, we consider three study designs: i) within subjects, within-
session (based on scan 1 and 2 from the within session dataset); ii) within subjects, between 
sessions (based on the baseline scans from the between session dataset); and iii) between 
subjects (based on scan 1 from the within session dataset and the first baseline scan from 
the between session dataset).  
Considering the bulk grey matter values reported, a significance level of 5% and a statistical 
power of 80%, the sample sizes (N) needed to detect effect sizes of 15%, 20% and 25% in 
the three study designs described are shown in Table 1.  
 
 OEF CBF CMRO2 
 15% 20% 25% 15% 20% 25% 15% 20% 25% 
(i) within subjects, 
within session 
14 8 5 15 9 6 24 14 9 
(ii) within subjects, 
between sessions 
8 4 3 11 6 4 12 7 5 
(iii) between 
subjects 
20 11 7 28 16 10 40 23 15 
 
Table 1: Sample size needed to detect effect sizes of 15%, 20% and 25% in OEF, CBF and 
CMRO2 for three different study designs (significance level = 5%, statistical power = 80%).  
 
The lower numbers for case ii) compared to case i) seem counterintuitive and may just arise 
from uncertainty in variance estimates from our samples. Nevertheless, these calculations, 
supported by the repeatability analysis previously presented, suggest that our approach can 
be usefully applied with practical sample sizes. In order to avoid large cohorts, experimental 
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designs characterized by reduced variability in the data should be chosen, such as crossover 
and longitudinal.   
In conclusion with this study we have characterised the variability of the estimates obtained 
with our dcFMRI method, showing an overall consistency with literature reports and a good 
level of repeatability. Performance varies for the different physiological parameters and 
according to spatial resolution and study design. In particular the information supplied by 
grey matter maps is of extreme interest for studies focused on the spatial distribution of 
brain physiology, despite some reliability limitations compared to methods supplying bulk 
measurements. The level of variability in the data suggest that the dcFMRI approach can be 
applied usefully for appropriate experimental designs with sample sizes typically found in 
MRI studies.       
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Appendix	
 
The estimation framework used in this work for both the within-session and the between-
sessions datasets is described with more detail in the original paper from our centre 
(Germuska et al., 2016) and has already been applied in its Bayesian variant in a recent 
publication (Merola et al., 2017). The code used for the estimates is available in the Cardiff 
University data Catalogue at http://dx.doi.org/10.17035/d.2015.100126.  
A forward signal model is constructed by combining a detailed description of the arterial 
spin labelling  (ASL) signal developed by Woolrich and colleagues (Woolrich et al., 2006) and 
a model of the BOLD signal developed in our centre (Wise et al., 2013). Here we summarize 
the equations relating the estimated parameters OEF, CBF, CVR and CMRO2.  
The total MR signal STOT resulting from a dual-gradient echo (GRE) imaging sequence with a 
PASL PICORE, QUIPSS II scheme for ASL signal can be expressed as: 
 =			
	,
∗ (∆∗/	,∗ )    Eq. A-1 
Where SASL is the ASL signal and the BOLD contribution is accounted for by changes in 
transverse relaxation rate R2
*
. With regards to the latter, it can be expressed following the 
model first proposed by Wise and colleagues (Wise et al., 2013) and then optimised (Merola 
et al., 2016) as: 
∆∗ = 		[] 	  !" #
[$%&]
[$%&]
' − 1	*    Eq. A-2 
and     ! = 	 #1 + ,-		∆./, '    Eq. A-3  
Where [dHb] is the deoxy-haemoglobin concentration (0 for baseline), PaCO2 is the arterial 
partial pressure of O2, CVR is the cerebrovascular reactivity (in %∆CBF/mmHgCO2), θ is an 
optimised fitting parameter and K is a lumped parameter depending on cerebral blood 
volume, field magnitude and geometry. Then OEF can be calculated from the expression for 
[dHb]/[dHb]0 proposed by Wise and colleagues (Wise et al., 2013): 
[$%&]
[$%&]
=	1!−
1
[]0
 11 #2342−
1
!2342,0' 	+	[] #
1
!−1'*	   Eq. A-4 
Where [Hb] is the haemoglobin concentration, ϕ is the O2 carrying capacity of haemoglobin 
(1.34 ml O2/gHb, see Table 2) and CaCO2 is the arterial O2 content. OEF is then related to 
[dHb]0 by: 
[] = []⋅	467     Eq. A-5 
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The ASL contribution SASL can also be expressed, following Woolrich model (Woolrich et al., 
2006), as a sum of a static component (Ss) and a component due to perfusion (Sb): 
 =	8 +	&      Eq. A-6 
Where the static component is expressed in terms of changes in voxel magnetization M: 
8 =	9(1 + ∆9 9⁄ )    Eq. A-7 
So that changes in M0 are assumed to derive from a change in blood volume and water 
exchange. The perfusion component is then expressed in terms of changes of CBF and the 
kinetic PASL model: 
& =	9,&;<<$ 	2=7	 #1 + ,-	∙	∆./, ' + ?@ABCDE + (1 − )FG + @(AB − AB − HI) ∙ 	 C1 − 	

(JK
J) KL⁄ F + HIGM
           Eq. A-8 
Where M0,blood and T1b are respectively the baseline magnetization and the longitudinal 
relaxation time of blood, R = 	
J KL⁄  and with pn=1 for control and p=-1 for tag. Finally TI1, 
TI2 and δt are the times time to saturation, time to imaging and transit time defined by the 
QUIPSS II tagging scheme. The relationship between PaO2 and arterial T1b is taken to be 
linear (as per Ma and colleagues, (Ma et al., 2014)) and described by:  
A,& = 	N34 + O    Eq. A-9 
The unknown parameters were fixed to literature values, with b = -5x10
-4
 (extrapolated 
from Ma and colleagues, (Ma et al., 2014)) and c = 1.78 (from Lu and colleagues, (Lu et al., 
2004), see Table 2). With regards to the contribution of PetO2 and to PetCO2 to calculated 
CaO2 and ∆PaCO2 respectively, local variation of the haemodynamic response (hr(t)) was 
allowed modelling each of them separately as gamma-variate functions: 
     ℎQ(I) = 	 IR/S

ηT 		ηT 	IηT 		
ηTU UVWX⁄    Eq. A-10 
with tmax  (fixed to 0.2 s, see Table 2) denoting the time of peak and ηi free parameter 
determining the rise and fall times of the response (with i = CO2, O2). Finally CMRO2 is 
calculated as: 
294 = 467	2=7	2/4    Eq. A-11 
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Finally, Table 2 reports the main physiological parameters involved in the modelling with 
information about their role in the estimation process and values. 
 
 
 	
PARAMETER ROLE IN MODELLING VALUE UNITS 
OEF estimated prior: [0.35,0.1] - 
CBF estimated prior: [60,Inf] ml/100g/min 
CVR estimated prior: [3, 0.774] %/mmHg 
K estimated prior: [0.07, 0.087] - 
CMRO2 calculated Eq. A-11 µmol/100g/min 
PaCO2 measured - mmHg 
PaO2 measured - mmHg 
M0,blood measured - - 
θ fixed 0.06 - 
φ fixed 1.34 ml/g 
Hb fixed 15 g/dl 
T1b calculated Eq. A-9 s 
b; c (Eq. A-9) fixed -5x10-4; 1.78 s/mmHg; s 
tmax (Eq. A-10) fixed 0.2 s 
Table 2: List of main physiological parameters involved in the modelling. For each of them 
the role in the estimation process (“measured”, “estimated”, “calculated” or assumed 
“fixed”) and relative value (prior: [mean, standard deviation], fixed value or defining 
equation) and units are reported. 
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Figures	(captions)	
 
Figure 1: Top: diagram showing the experimental design for the within-session and 
between-sessions datasets. Bottom: list of indices calculated for each measure, both at 
whole grey matter (GM) and voxel-wise resolution. All indices were calculated for every 
repeatability considered: within session, between sessions - same day and between sessions 
– different day. [1] (McGraw and Wong, 1996) 
 
Figure 2: A - Inspired gas fractions during the respiratory task. B – Tidal traces of a single 
representative subject. C - End-tidal traces averaged across all subjects and sessions of the 
within-session dataset. Vertical lines highlight the timing of the respiratory task.  
In both B and C periods of hypercapnia and of hyperoxia are clearly visible, interleaved with 
short periods of normocapnia-normoxia. Positive and negative emphases can be 
distinguished before and after the plateau hyperoxic periods, respectively. As expected, 
periods of hyperoxia appear to produce a reduction in end-tidal CO2 and periods of 
hypercapnia are associated with slight increases in end-tidal O2. 
 
Figure 3: Scatterplots for the correlation analysis between the two sets of measurement 
(denoted as 1 and 2) of the within-session dataset. Dotted lines show unity and also 
displayed are the coefficient of determination (R
2
) and statistical significance (p). 
 
Figure 4: ICC and CV indices calculated at a grey matter level for all estimated parameters. 
A,B: within session dataset; C,D: between sessions, same day dataset; E,F: between 
sessions, different day dataset.  
Indices for individual subjects (CVintra and ICCglobal) are shown in black circles and dots while 
group indices (CVinter and ICCglobal) are shown in red stars and crosses respectively for ICC and 
CV.  
CVintra is the intra-subject CV and CVinter is the inter- subjects CV; ICCglobal is the ICC(A,k) 
calculated between subjects at a GM level and ICCspatial is the ICC(A,1) calculated within 
subjects across voxels. 
 
Figure 5: Voxel-wise CV indices calculated from the within-session dataset. A: results for 
<CVintra>, the mean across subjects of the intra-subject CV. B: results for CVinter, the inter-
subject CV. For both, reported are the axial views of the calculated maps for each 
physiological parameter and relative histograms showing the distributions of the calculated 
values (in red the median and in black the interquartile range limits).  
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Figure 6: Results of the repeatability analysis on the between-sessions dataset with 
measurements acquired in the same day. Scatterplots for the correlation analysis between 
the two sets of measurement (denoted as 1 and 2), for all four estimted physiological 
parameters. Displayed are the line of unity (dotted), the coefficient of determination (R
2
) 
and the statistical significance (p). 
 
Figure 7: Results of the repeatability analysis on the between-sessions dataset with 
measurements acquired in different days. Scatterplots for the correlation analysis between 
the two sets of measurement (denoted as 1 and 2), for all four estimted physiological 
parameters. Displayed are the line of unity (dotted), the coefficient of determination (R
2
) 
and the statistical significance (p). 
 
Figure 8: Voxel-wise CV indices calculated from the between-session dataset for the same 
day (A,B) or different day (C,D) case. Axial view of the calculated maps for each physiological 
parameter and relative histograms showing the distributions of the calculated values (in red 
the median and delimited in black the interquartile range). <CVintra> is the mean across 
subjects of the intra-subject CV and CVinter is the inter-subjects CV. 
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